Macquarie Group LTD Deciphera Pharmaceuticals, Inc. Transaction History

Macquarie Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$12.38 - $20.23 $3,231 - $5,280	-261 Reduced 6.33%	3,862 $76,000
Q4 2021 Feb 11, 2022	SELL	$7.7 - $37.13 $10,572 - $50,979	-1,373 Reduced 24.98%	4,123 $40,000
Q3 2021 Nov 12, 2021	BUY	$26.46 - $37.15 $92,371 - $129,690	3,491 Added 174.11%	5,496 $187,000
Q2 2021 Aug 13, 2021	BUY	$32.73 - $47.95 $31,224 - $45,744	954 Added 90.77%	2,005 $73,000
Q1 2021 May 14, 2021	SELL	$40.39 - $56.73 $13,005 - $18,267	-322 Reduced 23.45%	1,051 $47,000
Q2 2020 Aug 11, 2020	BUY	$37.05 - $65.03 $50,869 - $89,286	1,373 New	1,373 $82,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.